SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040110
Filing Date
2017-08-03
Accepted
2017-08-03 07:16:01
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471253_10q.htm 10-Q 384223
2 EXHIBIT 31.1 v471253_ex31-1.htm EX-31.1 10568
3 EXHIBIT 31.2 v471253_ex31-2.htm EX-31.2 10537
4 EXHIBIT 32.1 v471253_ex32-1.htm EX-32.1 4482
5 EXHIBIT 32.2 v471253_ex32-2.htm EX-32.2 4343
6 GRAPHIC pg18img1_10q.jpg GRAPHIC 125328
  Complete submission text file 0001144204-17-040110.txt   3655984

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20170630.xml EX-101.INS 849579
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20170630.xsd EX-101.SCH 35441
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20170630_cal.xml EX-101.CAL 31377
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20170630_def.xml EX-101.DEF 198914
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20170630_lab.xml EX-101.LAB 260655
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20170630_pre.xml EX-101.PRE 232736
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 171002786
SIC: 2834 Pharmaceutical Preparations